Human erythropoietin receptor increases GATA-2 and Bcl-xL by a protein kinase C-dependent pathway in human erythropoietin-dependent cell line AS-E2.
暂无分享,去创建一个
M. Tomonaga | Y. Miyazaki | K. Kuriyama | Y. Urata | T. Kondo | H. Tsushima | K. Fuchigami
[1] M. Tomonaga,et al. Establishment and characterization of a new erythropoietin-dependent acute myeloid leukemia cell line, AS-E2 , 1997, Leukemia.
[2] Xiaodong Wang,et al. Apaf-1, a Human Protein Homologous to C. elegans CED-4, Participates in Cytochrome c–Dependent Activation of Caspase-3 , 1997, Cell.
[3] K. Takeshita,et al. Selective expression of mRNA coding for the truncated form of erythropoietin receptor in hematopoietic cells and its decrease in patients with polycythemia vera. , 1997, Blood.
[4] R. Weichselbaum,et al. Role for Bcl-xL as an inhibitor of cytosolic cytochrome C accumulation in DNA damage-induced apoptosis. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[5] K. Norga,et al. Receptors that induce erythroid differentiation of Ba/F3 cells: structural requirements and effect on STAT5 binding. , 1997, Blood.
[6] S. Nagata,et al. Apoptosis by Death Factor , 1997, Cell.
[7] A. Sytkowski,et al. Protein Kinase C-ϵ Is Necessary for Erythropoietin's Up-regulation of c-myc and for Factor-dependent DNA Synthesis , 1996, Journal of Biological Chemistry.
[8] D Grillot,et al. Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2. , 1996, Blood.
[9] L. Zon,et al. Thrombopoietin rescues in vitro erythroid colony formation from mouse embryos lacking the erythropoietin receptor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[10] F. Verdier,et al. Erythropoietin‐induced erythroid differentiation of the human erythroleukemia cell line TF‐1 correlates with impaired STAT5 activation. , 1996, The EMBO journal.
[11] S. Korsmeyer,et al. Molecular thanatopsis: a discourse on the BCL2 family and cell death. , 1996, Blood.
[12] Y. Okano,et al. Protein kinase C isozymes in human megakaryoblastic leukaemia cell line, MEG‐01: possible involvement of the isozymes in the differentiation process of MEG‐01 cells , 1996, British journal of haematology.
[13] S. Busfield,et al. Regulation of the erythropoietin receptor and involvement of JAK2 in differentiation of J2E erythroid cells. , 1996, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[14] B. Calabretta,et al. Induction of hematopoietic commitment and erythromyeloid differentiation in embryonal stem cells constitutively expressing c-myb. , 1996, Blood.
[15] J. Cossman,et al. TPA-induced arrest of erythroid differentiation is coupled with downregulation of GATA-1 and upregulation of GATA-2 in an erythroid cell line SAM-1. , 1996, Blood.
[16] V. D’Agati,et al. Differential effects of an erythropoietin receptor gene disruption on primitive and definitive erythropoiesis. , 1996, Genes & development.
[17] W. Vainchenker,et al. Inhibition of protein kinase C suppresses megakaryocytic differentiation and stimulates erythroid differentiation in HEL cells. , 1996, Blood.
[18] Rudolf Jaenisch,et al. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor , 1995, Cell.
[19] B. Groner,et al. Interleukin-3, Erythropoietin, and Prolactin Activate a STAT5-like Factor in Lymphoid Cells (*) , 1995, The Journal of Biological Chemistry.
[20] Patrick R. Griffin,et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis , 1995, Nature.
[21] R. A. Mufson,et al. Human interleukin-3 receptor modulates bcl-2 mRNA and protein levels through protein kinase C in TF-1 cells. , 1995, Blood.
[22] A. Miyajima,et al. Interleukin 2 and erythropoietin activate STAT5/MGF via distinct pathways. , 1995, The EMBO journal.
[23] N. Copeland,et al. A novel cytokine‐inducible gene CIS encodes an SH2‐containing protein that binds to tyrosine‐phosphorylated interleukin 3 and erythropoietin receptors. , 1995, The EMBO journal.
[24] T. Tsuruo,et al. Aspartate-based inhibitor of interleukin-1 beta-converting enzyme prevents antitumor agent-induced apoptosis in human myeloid leukemia U937 cells. , 1995, Biochemical and biophysical research communications.
[25] M. Carroll,et al. Erythropoietin-induced cellular differentiation requires prolongation of the G1 phase of the cell cycle. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[26] S. Orkin,et al. GATA transcription factors: key regulators of hematopoiesis. , 1995, Experimental hematology.
[27] A. Sytkowski,et al. Erythropoietin activation of AP1 (Fos/Jun). , 1995, Experimental hematology.
[28] N. Komatsu,et al. Erythropoietin induces tyrosine phosphorylation and activation of phospholipase C-gamma 1 in a human erythropoietin-dependent cell line. , 1994, The Journal of biological chemistry.
[29] S. Nakazawa,et al. GATA-1, GATA-2, and stem cell leukemia gene expression in acute myeloid leukemia. , 1994, Leukemia.
[30] H. Marquardt,et al. Early transient suppression of c-myb mRNA levels and induction of differentiation in Friend erythroleukemia cells by the [Ca2+]i-increasing agents cyclopiazonic acid and thapsigargin. , 1994, The Journal of biological chemistry.
[31] T. Okada,et al. Blockage of chemotactic peptide-induced stimulation of neutrophils by wortmannin as a result of selective inhibition of phosphatidylinositol 3-kinase. , 1994, The Journal of biological chemistry.
[32] J. D. Engel,et al. Induction of erythroid-specific gene expression in lymphoid cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[33] K. Arai,et al. Signal transduction by the high‐affinity GM‐CSF receptor: two distinct cytoplasmic regions of the common beta subunit responsible for different signaling. , 1993, The EMBO journal.
[34] C. Thompson,et al. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death , 1993, Cell.
[35] J. D. Engel,et al. Dynamics of GATA transcription factor expression during erythroid differentiation. , 1993, Blood.
[36] O. Silvennoinen,et al. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin , 1993, Cell.
[37] J. D. Engel,et al. Ectopic expression of a conditional GATA-2/estrogen receptor chimera arrests erythroid differentiation in a hormone-dependent manner. , 1993, Genes & development.
[38] E. Melloni,et al. Role of δ-PKC on the Differentiation Process of Murine Erythroleukemia Cells , 1993 .
[39] H. Lodish,et al. Structure, function, and activation of the erythropoietin receptor. , 1993, Blood.
[40] H. Hug,et al. Protein kinase C isoenzymes: divergence in signal transduction? , 1993, The Biochemical journal.
[41] S. Hobbs,et al. Roles of erythropoietin, insulin-like growth factor 1, and unidentified serum factors in promoting maturation of purified murine erythroid colony-forming units. , 1992, Blood.
[42] T. Honjo,et al. Induced expression of PD‐1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. , 1992, The EMBO journal.
[43] H. Nakauchi,et al. A Truncated Erythropoietin Receptor That Fails to Prevent Programmed Cell Death of Erythroid Cells , 1992, Science.
[44] T. Taniguchi,et al. IL-2 and EGF receptors stimulate the hematopoietic cell cycle via different signaling pathways: Demonstration of a novel role for c-myc , 1992, Cell.
[45] K. O. Elliston,et al. A novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes , 1992, Nature.
[46] E. Lapetina,et al. Erythropoietin induces p21ras activation and p120GAP tyrosine phosphorylation in human erythroleukemia cells. , 1992, The Journal of biological chemistry.
[47] J. Szabó,et al. Human IL-3 induction of c-jun in normal monocytes is independent of tyrosine kinase and involves protein kinase C. , 1992, Journal of immunology.
[48] S. Busfield,et al. Erythropoietin-induced stimulation of differentiation and proliferation in J2E cells is not mimicked by chemical induction. , 1992, Blood.
[49] A. Sytkowski,et al. Induction of hemoglobin synthesis by downregulation of MYB protein with an antisense oligodeoxynucleotide. , 1991, Blood.
[50] A. Kraft,et al. Regulation of c-jun expression and AP-1 enhancer activity by granulocyte-macrophage colony-stimulating factor. , 1991, The Journal of biological chemistry.
[51] A. Sytkowski,et al. Erythropoietin increases c-myc mRNA by a protein kinase C-dependent pathway. , 1991, The Journal of biological chemistry.
[52] A. D’Andrea,et al. Human erythropoietin receptor: cloning, expression, and biologic characterization. , 1990, Blood.
[53] F. Dautry,et al. Northern blot normalization with a 28S rRNA oligonucleotide probe. , 1989, Nucleic acids research.
[54] R. Watson,et al. Down-regulation of c-myb gene expression is a prerequisite for erythropoietin-induced erythroid differentiation. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[55] M. Koury,et al. Maintenance by erythropoietin of viability and maturation of murine erythroid precursor cells , 1988, Journal of cellular physiology.
[56] M. Shibuya,et al. Genistein, a specific inhibitor of tyrosine-specific protein kinases. , 1987, The Journal of biological chemistry.
[57] M. Steinmetz,et al. IL3-dependent mouse clones that express B-220 surface antigen, contain ig genes in germ-line configuration, and generate B lymphocytes in vivo , 1985, Cell.
[58] Y. Nishizuka. Turnover of inositol phospholipids and signal transduction. , 1984, Science.
[59] M. Muramatsu,et al. Rapid isolation of nucleoli from detergent purified nuclei of various tumor and tissue culture cells. , 1974, Experimental cell research.